A Claude model autonomously chose a gene therapy and operated on a mouse brain with no human decision-making
AI-generated summary According to Exin Therapeutics cofounder and CEO Gabriel Ocana-Santero, a Claude model is said to have autonomously selected a gene therapy and performed surgery on a mouse brain. The autonomous agent refused to bypass a safety restriction during the procedure after a connection dropped and its calculated target position fell outside the device physical range of motion.
Also covered by WIRED tomshardware.com